Wells Fargo Maintains NOV Inc(NOV.US) With Sell Rating, Maintains Target Price $16
Wells Fargo Downgrades NOV Inc(NOV.US) to Sell Rating, Cuts Target Price to $16
NOV Is Maintained at Overweight by Morgan Stanley
NOV Analyst Ratings
Morgan Stanley Maintains Overweight on NOV, Lowers Price Target to $23
Morgan Stanley Maintains NOV Inc(NOV.US) With Buy Rating, Cuts Target Price to $23
A Quick Look at Today's Ratings for NOV Inc(NOV.US), With a Forecast Between $24 to $28
NOV Analyst Ratings
NOV (NOV) Receives a Rating Update From a Top Analyst
NOV Price Target Maintained With a $24.00/Share by RBC Capital
RBC Capital Reiterates Sector Perform on NOV, Maintains $24 Price Target
A Quick Look at Today's Ratings for NOV Inc(NOV.US), With a Forecast Between $25 to $28
A Quick Look at Today's Ratings for NOV Inc(NOV.US), With a Forecast Between $20 to $27
NOV Analyst Ratings
A Quick Look at Today's Ratings for NOV Inc(NOV.US), With a Forecast Between $20 to $27
Stifel Nicolaus Keeps Their Buy Rating on NOV (NOV)
NOV Analyst Ratings
Piper Sandler Maintains Neutral on NOV, Lowers Price Target to $20
Piper Sandler Gives a Hold Rating to NOV (NOV)
TD Cowen: Maintaining the NOV (NOV.US) rating, adjusted from buy to buy rating, and the target price was adjusted from $27.00 to $26.00.